Eye Biomarkers Show Promise for Early Detection of Systemic Diseases

Advances in artificial intelligence and imaging technology are accelerating the field of oculomics, which studies eye biomarkers for systemic diseases. This approach holds potential for earlier detection and intervention in various conditions, including neurodegenerative, cardiovascular, and metabolic disorders. Oculomics could offer a non-invasive method for identifying widespread health issues.